EGFR-directed tyrosine kinase inhibitors for non-small cell lung cancer
Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases and remains a leading cause of cancer-related deaths globally. While conventional chemotherapy has provided modest benefits, its toxicity and limited efficacy have underscored the need for more precise treatme...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Penerbit Universiti Kebangsaan Malaysia
2025
|
| Online Access: | http://journalarticle.ukm.my/25993/ http://journalarticle.ukm.my/25993/1/SML%2012.pdf |